Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2005
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1192775C Prophylactic and therapeutic use of oltipraz as antifibrotic and anticirrhotic agent in liver and pharmaceutical composition containing oltipraz
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/15/2005CA2063671C Aminoguanidines
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021533A1 Substituted isoquinoline derivatives and methods of use
03/10/2005WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2004096128A3 Hiv integrase inhibitors
03/10/2005US20050054856 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control
03/10/2005US20050054721 3-Aryl-4-Hydroxyfuranone compounds and the human and animal health use thereof
03/10/2005US20050054717 Coumarin derivative
03/10/2005US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas
03/10/2005US20050054709 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054657 Induce immunology response; anticancer agents
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054654 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
03/10/2005US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054630 Fused bicyclic carboxamide derivatives and methods of their use
03/10/2005US20050054629 Antiproliferative agents; anticancer agents; restenosis
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2537123A1 New compounds
03/10/2005CA2535896A1 N-substituted benzimidazolyl c-kit inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511491A1 Derivatives of azepine and thiazepan as interleukin converting enzyme inhibitors
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/09/2005CN1590378A Quinoxaline derivative and its preparation method and use
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1192031C Epothilones derivatives, their synthesis and uses
03/09/2005CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/09/2005CN1192022C Novel compound
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1191757C Substituted thienyl (amino) sulphonyl (thio) ureas as herbicides
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864375 Thiophene derivatives; an electrooptic device such as a waveguide, switch, modulator, coupler, router, (tele)communications system, data transmission device, and a interferometric optical modulator or switch
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864267 Calcilytic compounds
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005CA2261680C Fluorine-containing 1,4-disubstituted piperidine derivatives
03/03/2005WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
03/03/2005WO2005019200A2 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019196A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them
03/03/2005WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
03/03/2005WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019176A1 Substituted amino-aza-cyclohexanes
03/03/2005WO2005019168A2 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
03/03/2005WO2005018557A2 Substituted pyridinones
03/03/2005WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
03/03/2005WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/03/2005US20050049413 Quinoline derivatives
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049290 Benzimidazole derivatives and their use as gnrh antagonists
03/03/2005US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate
03/03/2005US20050049274 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one
03/03/2005US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer
03/03/2005US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders
03/03/2005US20050049253 Substituted quinolinone derivatives and methods of use
03/03/2005US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
03/03/2005US20050049247 Pyrimidines useful as modulators of voltage-gated ion channels
03/03/2005US20050049238 Heterocyclic retinoid compounds
03/03/2005US20050049237 Pyrazole-amides and -sulfonamides
03/03/2005US20050048092 Thienyl-pyrazoles and their use for controlling pests
03/03/2005CA2536435A1 Drug containing chymase inhibitor as the active ingredient
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2533396A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509514A1 Anthelmintic and insecticidal thiophene derivatives
03/02/2005EP1509505A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 523